DaxibotulinumtoxinA for injection
Sponsors
Revance Therapeutics, Inc.
Conditions
Cervical DystoniaFrown LinesLateral Canthal LinesUpper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)
Phase 2
Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)
CompletedNCT03786770
Start: 2019-01-24End: 2020-03-09Updated: 2023-02-16
Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines
CompletedNCT03911102
Start: 2019-03-11End: 2020-04-23Updated: 2023-06-27
Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines
CompletedNCT04259086
Start: 2019-12-06End: 2020-11-02Updated: 2023-06-27
Phase 3
Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)
CompletedNCT03608397
Start: 2018-06-20End: 2020-06-16Updated: 2022-12-05
Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)
CompletedNCT03617367
Start: 2018-09-05End: 2021-05-25Updated: 2022-01-28